- 英文名称2-Phenyl-1,3,5-Triazine
- 中文名称2-苯基-1,3,5-三嗪
- IUPAC名称2-phenyl-1,3,5-triazine
- 其它别名苯基-1,3,5-三嗪; Phenyl-1,3,5-Triazine
- CAS编号1722-18-5
- MFCD编号:MFCD16619132
- 分子式:C9H7N3分子量:157.18
- 产品CID: 882270
- 产品分类有机原料→分子砌块→芳杂环类化合物→三嗪类化合物
上下游产品
1,3,5-Triazine benzamidine monohydr°Chloride benzamidin 2,4-bis(methylthio)-6-phenyl-1,3,5-triazine 📜2,4-Bis(Methylthio)-6-Phenyl-1,3,5-Triazine置于1,4-二氧六环,镍体系中,化学反应生成苯基-1,3,5-三嗪
参考文献:Grundmann Et Al.,Chemische Berichte,1953,Vol. 86,P. 181,184
标题:Grundmann Et Al.,Chemische Berichte,1953,Vol. 86,P. 181,184
专利信息
专利号:US-8329923-B2
优先权日:2010-06-17
标 题:4, 4′ disubstituted 4H-cyclopentadithiophene and new methods for synthesizing the same
发明人:VANDERZANDE DIRK; LUTSEN LAURENCE; VAN MIERLOO SARAH
权利人:VANDERZANDE DIRK; LUTSEN LAURENCE; VAN MIERLOO SARAH; IMEC; UNIV HASSELT
摘要:The present preferred embodiments relate to a method for the synthesis of a compound having the following general formula: n nthe method comprising the step of reacting, in presence of a diprotic acid having a negative pKa, a compound having the general formula:n n nwherein R 1 and R 2 are organic groups and wherein X and Y are independently selected from the group consisting of hydrogen, chloro, bromo, iodo, boronic acid, boronate esters, borane, pseudohalogen and organotin. It further relates to compounds so obtained and to compounds resulting from the ring closure of compound (II).
专利号:US-7687635-B2
优先权日:2002-01-22
标 题:Metal complexes useful in metathesis and other reactions
发明人:VERPOORT FRANCIS WALTER CORNELIUS; DE CLERCQ BOB
权利人:TELENE S A S
摘要:This invention provides metal complexes being useful as catalyst components in metathesis reactions and in reactions involving the transfer of an atom or group to an ethylenically or acetylenically unsaturated compound or another reactive substrate and, with respect to a sub-class thereof, for the polymerisation of α-olefins and optionally conjugated dienes, with high activity at moderate tempera-tures. It also provides methods for obtaining polymers with very narrow molecular weight distribution by means of a living reaction. It also provides methods for making said metal complexes and novel intermediates involved in such methods. It further provides derivatives of said metal complexes which are suitable for covalent bonding to a carrier, the product of such covalent bonding being useful as a supported catalyst for heterogeneous catalytic reactions. It also provides a direct one-step synthesis of pyrrole, furan and thiophene compounds from diallyl compounds.
专利号:WO-2006079916-A1
优先权日:2005-01-26
标 题 :Thieno [2,3-d] pyrimidine compounds as inhibitors of adp-mediated platelets aggregation
发明人:ENNIS MICHAEL DALTON; KORTUM STEVEN WADE; RAHMAN HAYAT; SCHWEITZER BARBARA ANN; TENBRINK RUTH ELIZABETH
权利人:PHARMACIA & UPJOHN CO LLC; ENNIS MICHAEL DALTON; KORTUM STEVEN WADE; RAHMAN HAYAT; SCHWEITZER BARBARA ANN; TENBRINK RUTH ELIZABETH
摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I): wherein A1, A2, A3, A4, A5, A6, A7, A8, X4, X6, R2, R4, R5, and R6 are as defined in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
专利号:CN-115485267-A
优先权日:2020-05-06
标题 :Synthesis of vinylcyclobutyl intermediates
专利号:US-6936600-B2
优先权日:1999-04-01
标题:Sorbitol dehrydrogenase inhibitors
发明人:CHU-MOYER MARGARET Y; MYLARI BANAVARA L; ZEMBROWSKI WILLIAM J
权利人:PFIZER
摘要:This invention is directed to sorbitol dehydrogenase inhibitory compounds of the formula I, n n nwherein R 1 , R 2 and R 3 are as defined in the specification. This invention is also directed to pharmaceutical compositions containing those compounds and methods of treating or preventing diabetic complications, particularly diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy, diabetic macroangiopathy and diabetic cardiomyopathy by administering such compounds to a mammal suffering from diabetes and therefore at risk for developing such complications. This invention is also directed to pharmaceutical compositions comprising a combination of a compound of formula I of this invention with an aldose reductase inhibitor and to methods of treating or preventing diabetic complications therewith. This invention is also directed to pharmaceutical compositions comprising a combination of a compound of formula I of this invention with an NHE-1 inhibitor and to methods of treating cardiomyopathy and other heart-related problems therewith. This invention is also directed to certain intermediates used in the synthesis of the compounds of formula I and to processes for preparing those intermediates.
专利号:CN-110831934-B
优先权日:2017-05-12
标 题:Method for the synthesis of N-acyl compounds without the use of organic solvents or acid chlorides